Prevention of postpartum haemorrhage
The full guidance on the prevention of postpartum haemorrhage has been published in the International Journal of Gynecology and Obstetrics 2007;99(supp 2):S198-201, and is available as a read-only pfd file here.
|
Recommended Dosage: 600mcg orally or sublingually stat |
These recommendations are produced by an expert group on misoprostol brought together by WHO in Bellagio, Italy in Feb 2007. These recommendations do not reflect official WHO guidelines, but have been released early so as to provide guidance to clinicians worldwide. The excerpt above is taken from:
Z Alfirevic, J Blum, G Walraven, A Weeks, B Winikoff. Prevention of Postpartum Hemorrhage with Misoprostol. International Journal of Gynecology and Obstetrics 2007;99(supp 2):S198-201.
Alternative Guidelines
Additional guidelines for the prevention of postpartum haemorrhage are available here.
Postpartum Haemorrhage Prophylaxis
*STAT = single dose taken immediately
Route
Dose
Time period
Max. Dose
Level of evidence
Notes
Bellagio/
FIGO
Orally
Sublingual
600µg
600µg
STAT
STAT
1
1
IA
Not as effective as oxytocin or ergometrine. Exclude second twin before administration.
Do not repeat within 2 hours.
WHO
Oral
600µg
STAT
1
I A
Only use if there is no oxytocic treatment available
As LAST RESORT
NICE
-
-
-
-
-
No Guidelines
RCOG
Oral
600µg
STAT
1
IA
Warns of adverse effects
SOGC
Oral
Sublingual
Rectal
600-800 µg
STAT
1
II-1 B
Should combine with IM injection 0.2 mg Ergovine
ACOG
-
-
-
-
-
Gynuity
Oral
600 µg
STAT
1
IB
Administer in 3rd stage of labour – part of AMTSL
Additional Misoprostol should NOT be given after initial 6 hours of this dose
POPPHI
Oral
600µg
STAT
1
IB
Exclude second baby
Take tablet one minute after birth and perform uterine massage immediately
FLASOG
Oral
Rectal
600µg
600µg
STAT
STAT
1
1
IB
Use as last line treatment only if no alternative is available
|
Postpartum Haemorrhage Prophylaxis *STAT = single dose taken immediately |
||||||
|
|
Route |
Dose |
Time period |
Max. Dose |
Level of evidence |
Notes |
|
Bellagio/ FIGO |
Orally Sublingual |
600µg 600µg |
STAT STAT |
1 1 |
IA |
Not as effective as oxytocin or ergometrine. Exclude second twin before administration. Do not repeat within 2 hours. |
|
WHO |
Oral |
600µg |
STAT |
1 |
I A |
Only use if there is no oxytocic treatment available As LAST RESORT |
|
NICE |
- |
- |
- |
- |
- |
No Guidelines |
|
RCOG |
Oral |
600µg |
STAT |
1 |
IA |
Warns of adverse effects |
|
SOGC |
Oral Sublingual Rectal |
600-800 µg |
STAT |
1 |
II-1 B |
Should combine with IM injection 0.2 mg Ergovine |
|
ACOG |
- |
- |
- |
- |
- |
|
|
Gynuity |
Oral |
600 µg |
STAT |
1 |
IB |
Administer in 3rd stage of labour – part of AMTSL Additional Misoprostol should NOT be given after initial 6 hours of this dose |
|
POPPHI |
Oral |
600µg |
STAT |
1 |
IB |
Exclude second baby Take tablet one minute after birth and perform uterine massage immediately |
|
FLASOG |
Oral Rectal |
600µg 600µg |
STAT STAT |
1 1 |
IB |
Use as last line treatment only if no alternative is available |
